Navigation Links
Concentra Expands Medical Services within the Dallas-Fort Worth area
Date:1/17/2013

LEWISVILLE, Texas, Jan. 17, 2013 /PRNewswire/ -- Concentra, a subsidiary of Humana, announces the opening of its newest Concentra Urgent Care location in Lewisville located at 2403 South Stemmons Freeway.  The 8,300 square foot location is the second center within Denton County and one of the company's largest centers. 

(Logo: http://photos.prnewswire.com/prnh/20120529/MM15008LOGO)

In efforts to expand its medical footprint within the Dallas-Fort Worth market, the new Lewisville location has been established to better serve clients and patients throughout the Metroplex. The new center combines a premium environment with skilled and trusted medical care to provide a greater focus on the entire medical visit.   Ready to provide uninterrupted delivery of care, our full offering of occupational and urgent medical care, physical therapy, and health and wellness services will be available weekdays from 8:00 a.m. – 8:00 p.m., as well as weekends from 9:00 a.m. – 5:00 p.m. 

"We are excited to bring our expertise in urgent care and patient experience with the new Lewisville location, which meets the necessary medical services for Dallas-Fort Worth's growing population," said Bob Hassett , M.D., Vice President of Medical Operations for Concentra.  "By revolutionizing our health care practice here at Concentra, we continue to advance in the delivery of quality and efficient health care services to patients with a comfortable and stress-free environment that helps set patient expectations."

The medical center is conveniently located near the Sam Rayburn Tollway (Highway 121) and South Stemmons Freeway (I-35W), providing easy access to nearby communities and businesses. Concentra's Urgent Care center in Lewisville features the company's signature design and upscale interior elements to create a warm and relaxing atmosphere. The center has 12 patient exam rooms, a spacious physical therapy area, digital x-ray technology, and a bold graphic directional system. Taking a note from the hotel industry, the new center is designed from the patient's perspective, with every element working to create an exceptional experience. 

For more than 30 years, Concentra has been the leading provider of occupational and acute care services. With more than 330 national locations, Concentra offers quality, efficient medical care, at convenient times and locations, to meet patients' health care needs. The company's exceptional patient experience continues to gain recognition for outstanding service and customer loyalty, in the health industry and beyond. 

About Concentra

Concentra, a subsidiary of Humana Inc., is a leading health care company focused on improving America's health, one patient at a time. Through its affiliated clinicians, the company provides occupational medicine, urgent care, primary care, physical therapy, and wellness services from more than 330 medical centers in 40 states. In addition to these medical center locations, Concentra serves employers by providing a broad range of health advisory services and operating more than 270 worksite medical facilities. Through this complement of services, Concentra intends to raise the standard of health by putting individuals first, treating them with clinical excellence, and focusing on their ongoing wellness. www.Concentra.com

About Humana

Humana Inc., headquartered in Louisville, Kentucky, is a leading health care company that offers a wide range of insurance products and health and wellness services that incorporate an integrated approach to lifelong well-being. By leveraging the strengths of its core businesses, Humana believes it can better explore opportunities for existing and emerging adjacencies in health care that can further enhance wellness opportunities for the millions of people across the nation with whom the company has relationships.

More information regarding Humana is available to investors via the Investor Relations page of the company's web site at www.humana.com, including copies of:

  • Annual reports to stockholders;
  • Securities and Exchange Commission filings;
  • Most recent investor conference presentations;
  • Quarterly earnings news releases;
  • Replays of most recent earnings release conference calls;
  • Calendar of events (including upcoming earnings conference call dates and times, as well as planned interaction with research analysts and institutional investors);
  • Corporate Governance information


'/>"/>
SOURCE Concentra
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Biodel Awarded NIH Grant to Develop Concentrated Ultra-Rapid-Acting Insulin Formulations for Use in Artificial Pancreas
2. Maximum-Strength Formulation Offers Highest Concentration and Purity
3. AssureRx Health Expands Management Team to Support Increasing Business Growth
4. Cumberland Emerging Technologies Expands Life Sciences Center
5. VWR International, LLC Expands European Portfolio With Acquisitions Of Labonord SAS And Switch BVBA
6. More Practices Join RainTree Oncology Network As Company Expands Presence In Community Oncology
7. Boston Healthcare Expands Health Economics, Pricing, and Reimbursement Consulting Practice in Asia
8. Integrated Marketing Company Expands Into Canada
9. Inovio Expands Synthetic Vaccine Intellectual Property License With University of Pennsylvania
10. SAFC Expands PharmaGrade Raw Materials Portfolio for Biopharmaceutical Manufacturing
11. ProNAi Expands Management Team and Presents Encouraging Phase I Study Results for Lead Cancer Drug at Cancer Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Feb. 23, 2017 ... clinical-stage oncology drug development company, announces that it ... Drug Administration (FDA) authorizing the initiation a Phase ... treatment for pancreatic cancer. MVT-1075 ( 177 Lu-CHX-A?-DTPA-HuMab5B1) ... (RIT). MabVax plans to initiate the phase I ...
(Date:2/23/2017)... VANCOUVER, British Columbia , Feb. 23, ... ) today announced its year end 2016 financial results.  ... January 2017, OncoGenex, and Achieve Life Science, Inc., a privately ... into a definitive merger agreement under which OncoGenex will ... the proposed merger, Achieve,s stockholders are expected to own ...
(Date:2/23/2017)... 2017 This report analyzes analyzes the worldwide markets for ... comprehensive analytics for the US, Canada , ... Asia-Pacific , Latin America ... provided for the period 2015 through 2022. Also, a six-year ... analytics are derived from primary and secondary research. Company profiles ...
Breaking Medicine Technology:
(Date:2/22/2017)... , ... February 22, 2017 , ... Gevir, a New ... antler velvet, announced its products are coming soon to Amazon.com, the world’s largest online ... Thomson as a means to develop an effective natural treatment for Shelley’s Multiple Sclerosis, ...
(Date:2/22/2017)... CA (PRWEB) , ... February 22, 2017 , ... ... treatment to the thousands of individuals who have recently fallen victim to America’s opioid ... in Orange County, California, where they are free from the shame, stigma, and ...
(Date:2/22/2017)... ... February 22, 2017 , ... The National Academy of Certified ... the April 2017 testing period. NACCM, a nonprofit organization, has provided the premier ... exam is periodically re-calibrated to ensure that newly certified professionals are prepared to ...
(Date:2/22/2017)... ... February 22, 2017 , ... Giving patients with diabetes customized ... room, fewer hospital admissions, and better blood pressure and glycemic control, a ... study can be found here . , The study comes as health ...
(Date:2/22/2017)... ... February 22, 2017 , ... In a 2012 survey, over ... not filling a prescription because they could not afford to pay for it. ... were 30-60%*. At the same time, hospitals, pharmacies, manufacturers and nursing ...
Breaking Medicine News(10 mins):